Impact of the COVID-19 Pandemic on Quantity and Characteristics of Ophthalmology Consults
Introduction
At the height of the COVID-19 pandemic in New York, Montefiore Medical Center in The Bronx was at nearly 150% capacity to care for patients admitted with COVID-19.1 To meet patient care needs and minimize infectious disease spread, medical providers across specialties implemented enormous workflow changes.2–5 In ophthalmology, outpatient clinics covered only emergencies, while many resident physicians functioned as internists, caring for admitted patients with COVID-19.6 The purpose of this study is to assess the risk of in-hospital ophthalmologist exposure to COVID-19 and determine impact of the pandemic peak on ophthalmology consultations at one of the most affected hospital systems in New York.
Methods
In a retrospective cross-sectional, institutional chart review study, 2,215 ophthalmology consult notes were collected from the electronic medical record and analyzed with the assistance of a biostatistician. The study was compliant with the Health Insurance Portability and Accountability Act and the tenants of the Helsinki Declaration. The International Review Board at Albert Einstein College of Medicine provided prospective approval for reviewing and analyzing consult notes written in the electronic medical record between February 1, 2019 through May 31, 2019 and February 1, 2020 through May 31, 2020. Notes included those written for patients admitted to the Emergency Department (ED), inpatient floors, and intensive care units (ICUs). Surgical and outpatient clinic notes were excluded. The consult notes were classified as Initial consults, Follow-up consults, and Electronic consults (E-consults). The E-consult was first available for use on March 3, 2020.
The weekly number of total consults was compared between 2019 and 2020 by t-test. Initial consult notes were used to compare the characteristics of consults between 2019 and 2020. Only Initial consults were analyzed to avoid counting the same patient multiple times, as would occur if Initial, E-consult, and Follow-up notes were all included. Using only Initial notes also eliminated biases due to the E-consult note, which was only available in 2020. Data are based on count (% of Initial Notes). p-Value is from the proportion test to compare the rate between 2 years.
Consult characteristics analyzed included demographics, primary hospital diagnosis, chronic medical conditions (body mass index [BMI], diabetes mellitus, hypertension, coronary artery disease [CAD], chronic obstructive pulmonary disease [COPD]), location of consult (ED ICUs, inpatient floor), ventilatory status, procedures performed, reasons for consult request, and diagnosis by the ophthalmologist. t-Test was used for continuous variables and Fisher’s exact test was applied to categorical variables. For all analyses, a p-value of less than or equal to 0.05 was considered statistically significant.
Results
Of 2,215 total notes analyzed, consults decreased from 1,374 in 2019 (average 76/week) to 841 in 2020 (average 47/week) (p = 0.0002, by t-test). The total notes in 2019 included 912 Initial consults, 462 Follow-up consults, and zero E-consults (format not available in 2019). The total notes in 2020 included 480 Initial consults, 346 Follow-up consults, and 15 E-consults. Within 2020, the number of consults decreased significantly in late February (−47.5%) and in mid-March (−44.1%) when compared with the week prior for each (Fig. 1). In 2020, 1.8% of all notes were in the E-consult format, first E-consult dated April 7, 2020. In 2020, 22.5% of all consult patients were COVID tested and 2.4% were positive within 2 weeks of in-person evaluation by ophthalmology.
The location of consult changed significantly between the years with fewer consults in the ED in 2020 (72.1% in 2019, 54% in 2020; p < 0.001, by Fisher’s exact test) and more consults to both the ICU (8.6% in 2019 and 18.3% in 2020; p < 0.001) and to the Inpatient Floors (19.7% in 2019, 28.1% in 2020; p < 0.001). In 2019, 369 patients were admitted primarily for ophthalmologic reasons; in 2020, this decreased to 154 (p = 0.002). In 2019, 7.5% of patients required ventilator support; this proportion increased significantly in 2020 to 10.8% (p = 0.04).
Bedside procedures dropped significantly from 2019 to 2020 (4.9% of initial consults in 2019, 2.6% of initial consults in 2020; p = 0.04). Despite the decrease in volume of procedures, the most common type of procedure for both years was corneal foreign body removal (46.5% of procedures in 2019, 50% of procedures in 2020) followed by eyelid laceration repair (11.6% in 2019, and 1.7% in 2020).
Baseline characteristics of consults between the 2 years did not differ significantly, such as age (42.2 years in 2019, 40.3 years in 2020; p = 0.21, by t-test) and gender (52.1% female 2019, 50.4% female in 2020; p = 0.57). Patient ethnicities between the 2 years differed significantly (p = 0.002). The Patient Unavailable category (selected if the patient did not provide this information) increased from 8.1% in 2019 to 15.2% in 2020. The rest of the categories exhibited a slight decrease: Spanish/Hispanic/Latino (39.6% in 2019, 36.5% in 2020), Not Spanish/Hispanic/Latino (47.1% 2019, 44.2% 2020), and Patient Declined/Not Applicable/Unknown (5.2% in 2019, 4.2% in 2020).
Chronic medical conditions did not significantly differ between the years; these included BMI (mean 27.8 in 2019, mean 27.2 in 2020; p = 0.46), Diabetes (23.4% in 2019, 20.2% in 2020; p = 0.20), hypertension (28.4% in 2019, 28.8% in 2020; p = 0.90), CAD (4.7% in 2019, 5.2% in 2020; p = 0.70), and COPD (1.6% in 2019, 1.7% in 2020; p > 0.99).
The three most frequent reasons for consultation remained stable between years: eye pain or pressure (16.4%, 14.1%, p = 0.79, by proportion test), trauma (13.1%, 13.7%, p > 0.99), and blurry vision (12.9%, 11.2%, p = 0.85) (Table 1). Following evaluation by the ophthalmologist, trauma was the most common diagnosis both years (14.0%, 15.2%; p = 0.95). In 2019, the next two most common diagnoses in 2019 were glaucoma (10.9%) and “miscellaneous” (8.0%). In 2020, they were retinopathy of prematurity (ROP) (11.2%) and “miscellaneous” (9.9%). For both years, the majority (61%) of “miscellaneous” diagnoses were eye exams requested by primary teams to identify ocular manifestations of a wide variety of systemic illnesses (Wilson’s disease, tuberculosis, autoimmune diseases, and congenital syndromes).
REASONS YEAR 2019 | NO. (%) | p | REASONS YEAR 2020 | NO. (%) | p |
---|---|---|---|---|---|
Eye pain or pressure | 148 (16.4) | 0.79 | Eye pain or pressure | 67 (14.1) | 0.79 |
Trauma | 118 (13.1) | >0.99 | Trauma | 65 (13.7) | >0.99 |
Blurry vision | 116 (12.9) | 0.85 | Blurry vision | 53 (11.2) | 0.85 |
Red eye | 106 (11.8) | 0.02 | Retinopathy of prematurity evaluation | 51 (10.8) | <0.001 |
Vision loss | 95 (10.6) | 0.43 | Vision loss | 35 (7.4) | 0.43 |
Swelling | 82 (9.1) | 0.43 | Swelling | 30 (6.3) | 0.43 |
Headaches | 72 (8.0) | 0.79 | Fungemia | 30 (6.3) | 0.20 |
Papilledema evaluation | 49 (5.4) | 0.90 | Red eye | 29 (6.1) | 0.02 |
Photophobia | 44 (4.9) | 0.87 | Headaches | 28 (5.9) | 0.79 |
Herpes evaluation | 40 (4.4) | 0.96 | Herpes evaluation | 25 (5.3) | 0.96 |
DIAGNOSES YEAR 2019 | NO. (%) | p | DIAGNOSES YEAR 2020 | NO. (%) | p |
Trauma | 126 (14.0) | 0.95 | Trauma | 72 (15.2) | 0.95 |
Glaucoma | 98 (10.9) | 0.68 | Retinopathy of prematurity | 53 (11.2) | <0.001 |
Miscellaneous | 72 (8.0) | 0.85 | Miscellaneous | 47 (9.9) | 0.85 |
Unremarkable eye exam | 54 (6.0) | 0.95 | Glaucoma | 39 (8.2) | 0.68 |
Decreased vision | 49 (5.4) | 0.68 | Unremarkable eye exam | 23 (4.9) | 0.95 |
Dry eye | 48 (5.3) | 0.61 | Corneal abrasion | 22 (4.6) | >0.99 |
Uveitis | 42 (4.7) | 0.83 | Zoster | 22 (4.6) | 0.68 |
Corneal abrasion | 41 (4.6) | >0.99 | Diabetic retinopathy | 21 (4.4) | 0.95 |
Diplopia | 40 (4.4) | 0.95 | Papilledema evaluation | 19 (4.0) | >0.99 |
Retinopathy of prematurity | 39 (4.3) | <0.001 | Diplopia | 17 (3.6) | 0.95 |
Discussion
Ophthalmology consults at a major New York City hospital system changed significantly during the COVID-19 pandemic peak in Spring 2020. Consult quantities decreased in late February, corresponding to the first COVID-19 case reported in New York State on February 29. There was also a drop in March, which may relate to the stay-at-home order on March 22 that required all New Yorkers to stay at home, except for essential workers.7 Overall, the number of patients admitted primarily for ophthalmologic care significantly decreased from 2019 to 2020. Following this trend, the number of consults and bedside procedures dropped significantly between years.
The proportion of ophthalmology consult patients in the ICU and on ventilators rose significantly from 2019 to 2020, reflecting the increased number of high-acuity patients admitted with COVID-19. There was a significant difference in patient ethnicities between the 2 years, although this is difficult to interpret given the limited available categories. The Patient Unavailable ethnicity category may have increased in 2020 due to the higher number of patients with respiratory distress, thus resulting in their inability to participate in patient registration as compared with those in 2019. At its peak pandemic volume on April 12, 2020, this 1,491-bed hospital system was overwhelmed with 2,208 patients admitted for COVID-19.1
To assess the risk of COVID-19 exposure to ophthalmologists during consultations, positive COVID-19 tests that resulted within 2 weeks of examination were included in this study. Although only 2.4% of consult patients tested COVID positive, this low number likely reflects the limited availability of tests in Spring 2020. At that time, patients were presumptively diagnosed with COVID-19 based on symptoms, imaging, and exposure, while tests were reserved for those with new or unusual respiratory symptoms or prolonged exposure, although guidelines changed frequently. Given the overwhelming number of patients admitted with COVID-19 symptoms, ophthalmologists likely had a much higher risk of COVID-19 exposure in the hospital than indicated by the number of patients with a positive test.
Despite the risk of COVID-19 exposure to providers and the advent of the newly available E-consult, the majority (98.2%) of consults in 2020 remained in-person evaluations. E-consults accounted for a small fraction (1.8%) of total consults in 2020. The E-consult was first available on March 3, 2020, although the first note was not dated until April 7, 2020. Despite the risks of face-to-face patient care, over a month passed before E-consult was used in ophthalmology. This delay in usage and low volume likely reflects lack of primary team awareness of the new E-consult modality, as well as the need for an in-person slit lamp and fundus exam to adequately assess the patient. Regardless of the reason, consulting ophthalmologists remained at risk of COVID-19 exposure during the peak of the COVID-19 pandemic.
Other institutions have successfully implemented virtual inpatient ophthalmology consultations, with high levels of patient satisfaction.8,9 In the future, teleophthalmology will likely play a larger role in inpatient ophthalmology care, especially in nonemergent cases.10–13 Adoption of these new technologies may fundamentally alter how ophthalmology is practiced, ushering in a new era in the delivery of ophthalmological care; especially in the outpatient practices.12 The nature of E-consults may improve both patient and ophthalmologist safety, especially during a respiratory illness pandemic.9
The top diagnoses in 2019 were trauma and glaucoma. In 2020, the top diagnoses were trauma and ROP. Despite the stay-at-home order in 2020, trauma was still the most common ophthalmology diagnosis among admitted patients. The prevalence of trauma is reflected in the procedure data as well, with eyelid laceration repair as one of the most common procedures in both years. This is likely due to the high volume of trauma cases in this hospital system’s catchment area of The Bronx, the most impoverished borough in New York City.14 Both COVID-19 and trauma cases may have been exacerbated by crowded living conditions and the consequential difficulty in adhering to social distancing guidelines.
Fewer patients had a diagnosis of glaucoma after an ophthalmology evaluation in 2020. This decrease may represent patients with routine ophthalmological concerns presenting less to the hospital in 2020 due to fear of contracting COVID-19. In contrast, ROP represented a greater percentage of ophthalmology diagnoses in 2020 than in 2019. This increase may reflect the fact that infants with ROP required hospital services in 2020 despite the risk for COVID-19 infection, thereby significantly increasing the relative percentage of cases in 2020.
Potential study limitations include the retrospective, single-institution nature of the study. The ethnicity data are limited due to the poorly descriptive nature of categories available in the electronic medical record. Furthermore, the quantity of bedside procedures may not reflect the true number. Only procedures documented in an Initial Consult Note were included, as per study protocol to ensure patients were counted once. Although the number of procedures is likely higher than reported, as they could have been documented in a Follow-Up Consult Note, Brief Note, or Procedure Note. Additionally, if diagnoses changed between initial and follow-up notes, the change was not reflected in these results. In the future, larger, multicenter studies examining the role of electronic or telemedicine consults would be valuable to establish their role during a pandemic.
Conclusion
With changing variants of COVID-19 and the possibility of other viral outbreaks, it is important for health care providers to learn from the most recent pandemic to improve future management. The quantity and characteristics of ophthalmology consultations at a major New York City hospital system changed significantly during the Spring 2020 COVID-19 pandemic peak. Although COVID-19 is a virulent respiratory illness, a strong demand remained for ophthalmology services in the ED, inpatient floors, and ICUs in 2020.
Given the prolonged and face-to-face nature of complete eye exams, ophthalmologists have an increased risk of exposure to COVID-19, as well as other respiratory illnesses.15,16 Reimbursement policies have become more supportive of telehealth due to the Coronavirus Preparedness and Response Supplemental Appropriations Act in March 2020, and ophthalmologists may be able to incorporate more telemedicine into triaging patients and into follow-up visits.13,17 Improving telemedicine for ophthalmology is a key area for development to maintain quality patient care and provide better protection for both patients and ophthalmologists during this and future pandemics.
Authors’ Contributions
All authors had the opportunity to view and contribute to the article before submission.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author, A.B., upon reasonable request.
Disclosure Statement
No competing financial interests exist.
Funding Information
No funding was received for this article.
References
- 1. https://www.nytimes.com/2020/06/09/opinion/coronavirus-racism-montefiore-medicine.html (Last accessed
October 9, 2021 ). Google Scholar I Fought Two Plagues and Only Beat One. The New York Times. 2020. Available at - 2. Managing a specialty service during the COVID-19 crisis: Lessons from a New York City health system. Acad Med 2020;95:1495–1498. Crossref, Medline, Google Scholar .
- 3. SARS-CoV-2 from the trenches: A perspective from New York City. AJR Am J Roentgenol 2020;215:27–28. Crossref, Medline, Google Scholar .
- 4. COVID-19 response in the global epicenter: Converting a New York City level 1 orthopedic trauma service into a hybrid orthopedic and medicine COVID-19 management team. J Orthop Trauma 2020;34:411–417. Crossref, Medline, Google Scholar
- 5. Restructuring electrophysiology during the COVID-19 pandemic: A practical guide from a New York City Hospital Network. Crit Pathw Cardiol 2020;19:105–111. Crossref, Medline, Google Scholar
- 6. Perspectives from the front lines of COVID-19: New York City ophthalmology resident narratives. Curr Opin Ophthalmol 2020;31:386–388. Crossref, Medline, Google Scholar
- 7. COVID-19 outbreak—New York City, February 29–June 1, 2020 [published correction appears in MMWR Morb Mortal Wkly Rep 2020;69:1930]. MMWR Morb Mortal Wkly Rep 2020;69:1725–1729. Crossref, Medline, Google Scholar
- 8. Evaluation of patient satisfaction with an ophthalmology video consultation during the COVID-19 pandemic. Ophthalmologe 2020;117:659–667. Crossref, Medline, Google Scholar
- 9. Initial results and patient survey of virtual inpatient ophthalmology consultations during the COVID-19 pandemic. Semin Ophthalmol 2021;36:461–468. Crossref, Medline, Google Scholar
- 10. To evaluate the effect of COVID-19 pandemic and national lockdown on patient care at a tertiary-care ophthalmology institute. Indian J Ophthalmol 2020;68:1540–1544. Crossref, Medline, Google Scholar
- 11. Teleconsultation in primary ophthalmic emergencies during the COVID-19 lockdown in Paris: Experience with 500 patients in March and April 2020. J Fr Ophtalmol 2020;43:577–585. Crossref, Medline, Google Scholar
- 12. Living with COVID-19: A perspective from New York area ophthalmology residency program directors at the epicenter of the pandemic. Ophthalmology 2020;127:e47–e48. Crossref, Medline, Google Scholar
- 13. Virtual ophthalmology: Telemedicine in a COVID-19 era. Am J Ophthalmol 2020;216:237–242. Crossref, Medline, Google Scholar .
- 14. https://www1.nyc.gov/assets/opportunity/pdf/18_poverty_measure_report.pdf (Last accessed
February 23, 2022 ). Google Scholar New York City Government Poverty Measure 2005–2016. NYC. 2018. Available at - 15. New York City COVID-19 resident physician exposure during exponential phase of pandemic. J Clin Invest 2020;130:4726–4733. Crossref, Medline, Google Scholar
- 16. Preparedness among ophthalmologists: During and beyond the COVID-19 pandemic. Ophthalmology 2020;127:569–572. Crossref, Medline, Google Scholar .
- 17. Incorporating telemedicine as part of COVID-19 outbreak response systems. Am J Manag Care 2020;26:147–148. Crossref, Medline, Google Scholar .